CCH Holdings Ltd Surges Amid GSK's Acquisition of Rapt Therapeutics
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 20 Jan 26
CCH Holdings Ltd's stock surged by 47.98% in pre-market trading as it crossed above the 5-day SMA, reflecting a strong positive reaction to the broader market's acquisition news.
The surge in CCH Holdings Ltd's stock is amid GSK's acquisition of Rapt Therapeutics for $58 per share, valued at $2.2 billion. This acquisition is expected to enhance GSK's market position and may lead to increased investor interest in related biotech firms, including CCH Holdings Ltd.
This acquisition could signal a shift in the biotech sector, prompting other companies to pursue similar strategic moves, which may benefit CCH Holdings Ltd as the market reacts positively to consolidation in the industry.
Analyst Views on CCHH
About CCHH
CCH Holdings Ltd is a specialty hotpot restaurant chains in Malaysia, specializing in chicken hotpot and fish head hotpot. The Company offers catering services in Malaysia and outside Malaysia mainly under two brands, namely Chicken Claypot House for its chicken hotpot restaurants and Zi Wei Yuan for its fish head hotpot restaurants through a combination of restaurant outlets and franchised restaurant outlets. The Company operates or licenses approximately 32 restaurant outlets, among which there are 20 Chicken Claypot House restaurant outlets, four Zi Wei Yuan restaurant outlets, three Chicken Claypot House-Zi Wei Yuan cross-over restaurant outlets, three restaurant outlets under the brand Bibixian focusing on Teochew-style chicken hotpot, a food court, and a restaurant outlet under the brand Banbudian Bistro offering Sichuan cuisine. It also has over four franchised restaurant outlets located in three other countries, including Thailand, Indonesia and China.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
